Citadel Advisors’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-154,764
| Closed | -$1.49M | – | 7289 |
|
|
2024
Q4 | $1.49M | Buy |
+154,764
| New | +$1.49M | ﹤0.01% | 2906 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6944 |
|
|
2024
Q2 | – | Sell |
-64,424
| Closed | -$206K | – | 7015 |
|
|
2024
Q1 | $206K | Buy |
+64,424
| New | +$206K | ﹤0.01% | 4769 |
|
|
2023
Q4 | – | Sell |
-746
| Closed | -$1.78K | – | 6823 |
|
|
2023
Q3 | $1.78K | Sell |
746
-87,319
| -99% | -$208K | ﹤0.01% | 5654 |
|
|
2023
Q2 | $155K | Sell |
88,065
-143,439
| -62% | -$252K | ﹤0.01% | 4559 |
|
|
2023
Q1 | $713K | Buy |
231,504
+189,791
| +455% | +$585K | ﹤0.01% | 3508 |
|
|
2022
Q4 | $221K | Sell |
41,713
-315,025
| -88% | -$1.67M | ﹤0.01% | 4603 |
|
|
2022
Q3 | $1.26M | Buy |
356,738
+284,164
| +392% | +$1M | ﹤0.01% | 3185 |
|
|
2022
Q2 | $187K | Buy |
72,574
+54,437
| +300% | +$140K | ﹤0.01% | 5029 |
|
|
2022
Q1 | $81K | Sell |
18,137
-6,877
| -27% | -$30.7K | ﹤0.01% | 5744 |
|
|
2021
Q4 | $170K | Buy |
+25,014
| New | +$170K | ﹤0.01% | 5591 |
|
|
2021
Q3 | – | Sell |
-20,710
| Closed | -$208K | – | 7242 |
|
|
2021
Q2 | $208K | Sell |
20,710
-115,348
| -85% | -$1.16M | ﹤0.01% | 5541 |
|
|
2021
Q1 | $1.3M | Buy |
+136,058
| New | +$1.3M | ﹤0.01% | 3643 |
|
|
2020
Q4 | – | Sell |
-44,515
| Closed | -$395K | – | 5704 |
|
|
2020
Q3 | $395K | Buy |
+44,515
| New | +$395K | ﹤0.01% | 3677 |
|